Company intelligence / Profile preview

MetaSystems

Baden-Württemberg, Germanymetasystems-international.com ↗

Ownership: Private
Employees: ~170
Development stage: Commercial

Overview

Over 13,400 devices installed in more than 2,800 laboratories across 103 countries. The company’s platforms are widely adopted in clinical cytogenetics and pathology labs as well as research institutions for high-throughput automated microscopy and advanced image/data management. Their deep learning solutions have received a US patent for AI-based chromosome analysis.

Modalities: DeviceSoftware platform for automated microscopy and imagingDNA/RNA FISH probesDeep learning-based image analysis tools
Industry: Pathology

Beyond the preview

Go deeper on MetaSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MetaSystems.

Explore the full profile